{"id":1666,"date":"2024-08-27T19:07:02","date_gmt":"2024-08-27T19:07:02","guid":{"rendered":"https:\/\/swisspresse.com\/jj-hrsa-at-loggerheads-over-340b-drug-pricing-for-stelara-and-xarelto\/"},"modified":"2024-08-27T19:07:02","modified_gmt":"2024-08-27T19:07:02","slug":"jj-hrsa-at-loggerheads-over-340b-drug-pricing-for-stelara-and-xarelto","status":"publish","type":"post","link":"https:\/\/swisspresse.com\/en\/jj-hrsa-at-loggerheads-over-340b-drug-pricing-for-stelara-and-xarelto\/","title":{"rendered":"J&#038;J, HRSA at Loggerheads Over 340B Drug Pricing for Stelara and Xarelto"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p><span class=\"LinkEnhancement\"><a class=\"Link\" href=\"https:\/\/www.biospace.com\/employer\/248231\/johnson-johnson-family-of-companies\" target=\"_blank\" rel=\"noopener\">Johnson &amp; Johnson<\/a><\/span> is proposing major changes to the way certain hospitals procure two of its biggest selling products under the 340B drug pricing program\u2014but the federal government is pushing back.<\/p>\n<p>J&amp;J <span class=\"LinkEnhancement\"><a class=\"Link\" href=\"https:\/\/www.documentcloud.org\/documents\/25060917-johnson-johnson-innovative-medicine-340b-rebate-model-policy-update-08-23-2024_final\" target=\"_blank\" rel=\"noopener\">announced modifications<\/a><\/span> on Friday to its 340B discount policy, noting that starting October 15, 2024, qualified hospitals can only obtain the pharma\u2019s anti-inflammatory antibody Stelara (ustekinumab) and blood thinner Xarelto (rivaroxaban) through a rebate program. Under the plan, hospitals will first have to pay for the full price of the drugs and&#8230;<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.biospace.com\/policy\/j-j-hrsa-at-loggerheads-over-340b-drug-pricing-for-stelara-and-xarelto\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson is proposing major changes to the way certain hospitals procure two of its biggest selling products under the 340B drug pricing program\u2014but the federal government is pushing back. J&amp;J announced modifications on Friday to its 340B discount policy, noting that starting October 15, 2024, qualified hospitals can only obtain the pharma\u2019s anti-inflammatory [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":{"0":"post-1666","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business"},"_links":{"self":[{"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/posts\/1666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/comments?post=1666"}],"version-history":[{"count":0,"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/posts\/1666\/revisions"}],"wp:attachment":[{"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/media?parent=1666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/categories?post=1666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/swisspresse.com\/en\/wp-json\/wp\/v2\/tags?post=1666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}